States and Lidoderm

SAN FRANCISCO – Seven years after the Federal Trade Commission launched its antitrust suit over the delay to market of a generic version of the Lidoderm painkiller patch – and nearly a year after settling the suit for $270 million – 18 states sued Endo Pharmaceutical on Friday over the issue.

%d bloggers like this: